Related Experiment Video
Updated: May 27, 2026

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
Complementary approaches to gauge the bioavailability and distribution of ingested berry polyphenolics
Mary Ann Lila1, David M Ribnicky, Leonel E Rojo
1Plants for Human Health Institute, North Carolina Research Campus, North Carolina State University , 600 Laureate Way, Kannapolis, North Carolina 28081, United States.
Investigating berry compounds like anthocyanins involved comparing a human gastrointestinal tract model (TIM-1) and rodent studies. TIM-1 showed anthocyanins from maqui berry and blueberry were bioaccessible within 2-3 hours.
Area of Science:
- Food Science
- Pharmacokinetics
- Nutritional Science
Background:
- Bioactive compounds in berries, such as anthocyanins and flavonoids, are of interest for their potential health benefits.
- Understanding the fate of these compounds after ingestion is crucial for assessing their bioavailability and efficacy.
- Existing methods for studying compound absorption and metabolism have limitations.
Purpose of the Study:
- To compare two distinct strategies for investigating the gastrointestinal fate of berry-derived anthocyanins and flavonoids.
- To evaluate the utility of the TIM-1 model for assessing anthocyanin bioaccessibility.
- To assess the in vivo absorption, transport, and clearance of biolabeled berry compounds in a rodent model.
Main Methods:
- Utilized the TIM-1 (Tissumat In Vivo-1) model, simulating the human gastrointestinal tract (mouth to ileum), to assess anthocyanin stability and bioaccessibility from maqui berry and wild blueberry.
- Employed biolabeled anthocyanins and flavonoids, generated in vitro from berry and grape cell cultures, for administration to rodent models.
- Monitored the absorption, transport, and urinary/colonic clearance of these labeled compounds in vivo.
Main Results:
- The TIM-1 model indicated that the majority of anthocyanins from both maqui berry and wild blueberry became bioaccessible between 2 and 3 hours post-ingestion.
- In vivo rodent studies allowed for the tracking and measurement of absorption, distribution, and excretion pathways of berry-derived flavonoids.
- Both methods provided complementary data on the pharmacokinetic behavior of berry constituents.
Conclusions:
- The TIM-1 model offers a valuable in vitro approach to assess the bioaccessibility of berry anthocyanins in a simulated human gastrointestinal environment.
- In vivo rodent models are effective for tracking the absorption, transport, and clearance of biolabeled berry compounds, providing insights into their systemic fate.
- Comparing these strategies highlights their respective strengths and limitations in elucidating the complex journey of bioactive berry constituents within the body.
Related Concept Videos
Measurement of Bioavailability: Pharmacodynamic Methods
Measurement of Bioavailability: Pharmacokinetic Methods
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability: Overview
Bioavailability: Overview
Bioavailability Study Design: Absolute Versus Relative Bioavailability

